Standigm named as a Tech Innovator in Generative AI in Drug Discovery use case
- Written by PR Newswire
![]() |
SEOUL, South Korea, Dec. 19, 2023 /PRNewswire/ -- Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, today announced that it has been included in a recent Gartner report, entitled, Emerging Tech: Tech Innovators for Generative AI NovelDrug Discovery.
About Standigm's technology
Standigm offers...
Read more: Standigm named as a Tech Innovator in Generative AI in Drug Discovery use case















